Target Name: LOC105378797
NCBI ID: G105378797
Review Report on LOC105378797 Target / Biomarker Content of Review Report on LOC105378797 Target / Biomarker
LOC105378797
Other Name(s): uncharacterized LOC105378797 | LOC105378797 variant X1 | Uncharacterized LOC105378797, transcript variant X1

LOC105378797: A Potential Drug Target and Biomarker

LOC105378797 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 6 and encodes a protein known as LOC105378797. LOC105378797 plays a crucial role in the development and maintenance of tissues, including the brain, and has been associated with various neurological disorders.

The search for potential drug targets and biomarkers has become an integral part of modern medicine. Drug targets are genes or molecules that are responsible for the production of proteins that are involved in the development or progression of diseases. Biomarkers are molecules that are used to monitor the progression of a disease and can be used to predict the outcome of a treatment.

LOC105378797: A Potential Drug Target

LOC105378797 is a gene that has been shown to be involved in the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. The protein encoded by this gene has been shown to play a crucial role in the development and progression of these disorders.

One of the key features of LOC105378797 is its involvement in the production of the tau protein. Tau is a protein that is known to be involved in the formation of neurofibrillary tangles, which are a hallmark of neurodegenerative disorders. The accumulation of tau protein in the brain is thought to contribute to the development and progression of these disorders.

In addition to its involvement in the production of tau protein, LOC105378797 has also been shown to play a role in the regulation of the microtubules in the brain. Microtubules are the structural elements that provide stability and movement to the chromosomes in the brain. The regulation of microtubules is critical for the proper functioning of the brain and has been implicated in the development and progression of neurodegenerative disorders.

LOC105378797: A Potential Biomarker

LOC105378797 has also been shown to be a potential biomarker for the diagnosis and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. The production of LOC105378797 has been shown to be decreased in the brains of individuals with these disorders, and the levels of LOC105378797 have been shown to be associated with the severity of these disorders.

In addition to its potential as a biomarker, LOC105378797 has also been shown to be involved in the development and progression of these disorders. The accumulation of LOC105378797 in the brain has been implicated in the development and progression of neurodegenerative disorders, and the regulation of LOC105378797 has been shown to play a crucial role in the development and progression of these disorders.

Conclusion

LOC105378797 is a novel gene that has recently been identified as a potential drug target and biomarker. The involvement of LOC105378797 in the production of tau protein and the regulation of microtubules in the brain suggests that it may be a valuable target for the development of new therapies for the treatment of neurodegenerative disorders. Further research is needed to determine the role of LOC105378797 in the development and progression of these disorders and to explore its potential as a

Protein Name: Uncharacterized LOC105378797

The "LOC105378797 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378797 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256